Absci Corp. (($ABSI)) has held its Q4 earnings call. Read on for the main highlights of the call. Absci Corp’s recent earnings call presented a ...

A patient with a rare illness would have died if it weren't for AI-powered drug repurposing: When side effects come to the ...

In a study on ovarian cancer cells, researchers from Karolinska Institutet demonstrate how the tumor environment influences ...

Pathology is a field that seems ripe for assistance from recent advances in artificial intelligence. Beck’s company is one of ...

Researchers have created an AI tool to accelerate the development of new disease treatments and demonstrated its potential by identifying an existing drug with the potential to prevent deadly heart ...

Researchers, executives, and thought leaders across healthcare gathered at NVIDIA GTC to discuss today’s pressing AI life science applications.

The market has been harsh on most growth stocks this year, owing primarily to tariff-related recession fears. In a volatile ...

"The clinical promise of pocenbrodib, our potential best-in-class CBP/p300 inhibitor, lies not only in its remarkable efficacy in resistant prostate cancer models, but also in our sophisticated ...

The company also announced a collaboration with chipmaker AMD to power its advanced de novo AI antibody design models, as well as AI biotechnology company Owkin to co-develop therapeutic candidates ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a ...

Conduit Pharmaceuticals advances its pipeline with key progress in preclinical lupus studies for AZD5658, Phase IIa trial design for AZD1656, ...

Unveiled updates across proprietary pipeline and demonstrated new breakthroughs by AI platform at 2024 R&D Day Entered into collaboration with AMD, including $20 million strategic investment in Absci ...